Results 261 to 266 of about 32,890 (266)

Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

New England Journal of Medicine, 2015
Mark G Lebwohl, Bruce E Strober, Alan Menter   +2 more
exaly  

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

New England Journal of Medicine, 2017
Ka Papp, Andrew Blauvelt, Melinda Gooderham   +2 more
exaly  

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

New England Journal of Medicine, 2010
Christopher Em Griffiths, Bruce E Strober, Peter Van De Kerkhof   +2 more
exaly  

Association Between Ustekinumab Trough Concentrations and Clinical, Biomarker, and Endoscopic Outcomes in Patients With Crohn’s Disease

Clinical Gastroenterology and Hepatology, 2017
Robert Battat, Uri Kopylov, Talat Bessissow   +2 more
exaly  

Ustekinumab

Reactions Weekly, 2016
openaire   +2 more sources

Ustekinumab: a promising new drug for SLE?

Lancet, The, 2018
exaly